دورية أكاديمية
Oligodendroglioma: a neurological perspective in Sub-saharan Africa.
العنوان: | Oligodendroglioma: a neurological perspective in Sub-saharan Africa. |
---|---|
المؤلفون: | James E; Department of Medicine and Surgery, University of Benin, Benin City, Edo state, Nigeria., Okon II; Department of Neurosurgery, Dell Medical School, University of Texas, Austin, TX, USA. inibeheokon3@gmail.com., Akpan U; Department of Public Health, Warwick Medical School, University of Warwick, Warwick, UK., Abigail O; Department of Biochemistry, University of Port Harcourt, Port-Harcourt, River State, Nigeria. |
المصدر: | Neurosurgical review [Neurosurg Rev] 2024 Jul 13; Vol. 47 (1), pp. 321. Date of Electronic Publication: 2024 Jul 13. |
نوع المنشور: | Journal Article; Review; Letter |
اللغة: | English |
بيانات الدورية: | Publisher: Springer Berlin Heidelberg Country of Publication: Germany NLM ID: 7908181 Publication Model: Electronic Cited Medium: Internet ISSN: 1437-2320 (Electronic) Linking ISSN: 03445607 NLM ISO Abbreviation: Neurosurg Rev Subsets: MEDLINE |
أسماء مطبوعة: | Publication: Berlin : Springer Berlin Heidelberg Original Publication: Berlin : Walter De Gruyter |
مواضيع طبية MeSH: | Oligodendroglioma*/diagnosis , Brain Neoplasms*/therapy , Brain Neoplasms*/diagnosis, Humans ; Africa South of the Sahara/epidemiology ; Female ; Male ; Adult |
مستخلص: | Gliomas are a kind of brain cancer that develops from glial cells. Glial cells provide nourishment and energy to nerve cells, and they also preserve the blood-brain barrier. A primary cancer of the central nervous system (CNS) is oligodendroglioma. This suggests that it originates in the brain or spinal cord. While oligodendrogliomas can strike anyone at any age, the age range of 35 to 44 is when they most commonly occur. Oligodendrogliomas are rare in young people and more common in men than women. Based on anecdotal data, patients with oligodendroglioma may present management challenges in Africa. There are delays in diagnosis and referrals due to the scarcity of neuroimaging facilities. A wide range of strategies have been put forth to improve pathology services in low- and middle-income nations. Adequate mentorship, short-term visitor programs, overcoming supply chain constraints, establishing training standards, and establishing the role of pathologists in cancer screening and early diagnosis have all been proposed as solutions to this problem. To sum up, oligodendroglioma is one of the low-grade gliomas this study looked at. Brain cancer is a serious public health concern in Africa. Improved options for screening and therapy are required to better address this problem. (© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.) |
References: | Michael CH, Fact Sheet on Oligodendroglioma (2021) : Cancer Association of South Africa, pp 1–9, https://cansa.org.za/files/2021/04/Fact-Sheet-on-Oligodendroglioma-NCR-2017-web-April-2021.pdf. Ooi SZY, de Koning R, Egiz A, Dalle DU, Denou M, Tsopmene MRD, Khan M, Takoukam R, Kotecha J, Sichimba D, Dokponou YCH, Kanmounye US, Bankole NDA (2022) Management and outcomes of low-Grade gliomas in Africa: a scoping review protocol. Int J Surg Protoc 26(1):1–6. https://doi.org/10.29337/ijsp.171 PMID: 35178489; PMCID: PMC8815446. (PMID: 10.29337/ijsp.171351784898815446) Tork CA, Atkinson C (2020) Oligodendroglioma. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan. 2020 Jun 10. Reifenberger G, Reifenberger J, Liu L et al Molecular Genetics of Oligodendroglial Tumors, in Nagai M (ed): Brain Research and Therapy. Toyko, Japan, Springer-Verlag, pp 187,1996 – 209. Wesseling P, van den Bent M, Perry A (2015) Oligodendroglioma: pathology, molecular mechanisms and markers. Acta Neuropathol 129(6):809–827. (PMID: 10.1007/s00401-015-1424-1259438854436696) Ohgaki H, Kleihues P (2005) Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol 64(6):479–489. (PMID: 10.1093/jnen/64.6.47915977639) Engelhard HH (2002) Current diagnosis and treatment of oligodendroglioma. Neurosurg Focus 12(2):E2. (PMID: 10.3171/foc.2002.12.2.316212319) Uwishema O, Frederiksen KS, Badri R, Pradhan AU, Shariff S, Adanur I, Dost B, Esene I, Rosseau G (2023) Epidemiology and etiology of brain cancer in Africa: a systematic review. Brain Behav 13(9):e3112. https://doi.org/10.1002/brb3.3112 Epub 2023 Jun 14. PMID: 37312649; PMCID: PMC10498065. (PMID: 10.1002/brb3.31123731264910498065) Nguembu S, Kanmounye U, Tétinou F, Djiofack D, Takoukam R (2020) Barriers to management of Nontraumatic Neurosurgical diseases at 2 Cameroonian Neurosurgical Centers: cross-sectional study. World Neurosurg 139:e774–e783. https://doi.org/10.1016/j.wneu.2020.04.162. (PMID: 10.1016/j.wneu.2020.04.16232376382) Okon II, Gbayisomore TJ, Kankam SB, Jalloh M (2024) Letter to the editor regarding cerebral blood Flow Role in Delineating Treatment Effect from true tumor progression in Glioblastoma Multiforme. World Neurosurg 186:269. https://doi.org/10.1016/j.wneu.2024.03.140. (PMID: 10.1016/j.wneu.2024.03.14038849997) Atallah O, Hammoud Z, Almealawy YF, Sanker V, Awuah WA, Abdul-Rahman T, Muthana A, Saleh A, Okon II, Chaurasia B, Rahman M, Kertam A, Badary A (2024) Recurrent artery of Heubner aneurysms in focus: insights into occurrence and current treatment paradigms. Neurochirurgie 70(5):101572 Advance online publication. https://doi.org/10.1016/j.neuchi.2024.101572. (PMID: 10.1016/j.neuchi.2024.10157238795614) Ndubuisi C, Mezue W, Nzegwu M, Okwunodulu O, Ejembi G, Ohaegbulam S (2017) The challenges of Management of High-grade gliomas in Nigeria. J Neurosci Rural Pract 8(3):407–411. https://doi.org/10.4103/jnrp.jnrp_18_17. (PMID: 10.4103/jnrp.jnrp_18_17286946215488562) |
فهرسة مساهمة: | Keywords: Cancer; Diagnosis; Gliomas; Oligodendroglioma; Tumor |
تواريخ الأحداث: | Date Created: 20240713 Date Completed: 20240713 Latest Revision: 20240713 |
رمز التحديث: | 20240714 |
DOI: | 10.1007/s10143-024-02579-7 |
PMID: | 39002027 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1437-2320 |
---|---|
DOI: | 10.1007/s10143-024-02579-7 |